BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17823236)

  • 1. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation.
    Li F; Wang X; Niyibizi C
    Stem Cells; 2007 Dec; 25(12):3183-93. PubMed ID: 17823236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases.
    Wang X; Li F; Niyibizi C
    Stem Cells; 2006 Aug; 24(8):1869-78. PubMed ID: 16675597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.
    Oyama M; Tatlock A; Fukuta S; Kavalkovich K; Nishimura K; Johnstone B; Robbins PD; Evans CH; Niyibizi C
    Gene Ther; 1999 Mar; 6(3):321-9. PubMed ID: 10435082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.
    Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K
    Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.
    Xia Z; Locklin RM; Triffitt JT
    Eur J Cell Biol; 2008 Jun; 87(6):353-64. PubMed ID: 18417247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice.
    Stover ML; Wang CK; McKinstry MB; Kalajzic I; Gronowicz G; Clark SH; Rowe DW; Lichtler AC
    Mol Ther; 2001 Apr; 3(4):543-50. PubMed ID: 11319916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells.
    Menuki K; Mori T; Sakai A; Sakuma M; Okimoto N; Shimizu Y; Kunugita N; Nakamura T
    Bone; 2008 Sep; 43(3):613-20. PubMed ID: 18567552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Participation of transfused bone marrow cells in reparative osteohistogenesis].
    Deev RV; Tsupkina NV; Serikov VB; Gololobov VG; Pinaev GP
    Tsitologiia; 2005; 47(9):755-9. PubMed ID: 16706204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo.
    Duan Y; Catana A; Meng Y; Yamamoto N; He S; Gupta S; Gambhir SS; Zern MA
    Stem Cells; 2007 Dec; 25(12):3058-68. PubMed ID: 17885076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene targeting in stem cells from individuals with osteogenesis imperfecta.
    Chamberlain JR; Schwarze U; Wang PR; Hirata RK; Hankenson KD; Pace JM; Underwood RA; Song KM; Sussman M; Byers PH; Russell DW
    Science; 2004 Feb; 303(5661):1198-201. PubMed ID: 14976317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.
    Horwitz EM; Prockop DJ; Fitzpatrick LA; Koo WW; Gordon PL; Neel M; Sussman M; Orchard P; Marx JC; Pyeritz RE; Brenner MK
    Nat Med; 1999 Mar; 5(3):309-13. PubMed ID: 10086387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental transplantation study for possible transformation of bone marrow cells in the mouse placenta.
    Kakui K; Itoh H; Sagawa N; Yura S; Takemura M; Kawamura M; Fujii S
    Placenta; 2005; 26(8-9):678-85. PubMed ID: 16085047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct stem cell lineages in murine bone marrow.
    Koide Y; Morikawa S; Mabuchi Y; Muguruma Y; Hiratsu E; Hasegawa K; Kobayashi M; Ando K; Kinjo K; Okano H; Matsuzaki Y
    Stem Cells; 2007 May; 25(5):1213-21. PubMed ID: 17218403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
    Eguchi H; Kuroiwa Y; Matsui A; Sada M; Nagaya N; Kawano S
    Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction.
    Zantop T; Gilbert TW; Yoder MC; Badylak SF
    J Orthop Res; 2006 Jun; 24(6):1299-309. PubMed ID: 16649228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.
    Rodriguez M; Alvarez-Erviti L; Blesa FJ; Rodríguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA
    Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
    Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
    Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development.
    Matsuda R; Yoshikawa M; Kimura H; Ouji Y; Nakase H; Nishimura F; Nonaka J; Toriumi H; Yamada S; Nishiofuku M; Moriya K; Ishizaka S; Nakamura M; Sakaki T
    Cell Transplant; 2009; 18(1):39-54. PubMed ID: 19476208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects.
    Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ
    Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.